Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7 Thoracic 5 CNS 3 Plasma cell 2 Other solid neoplasm 2 Breast 2 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Myeloproliferative Disorders 1

Interventions

fludarabine 63 Cyclophosphamide 63 venetoclax 58 Azacitidine 54 fludarabine phosphate 50 Specimen Handling 44 ruxolitinib 40 Whole-Body Irradiation 40 Mycophenolic Acid 37 Tacrolimus 35 Melphalan 32 Busulfan 32 Biopsy 32 Cytarabine 31 Decitabine 28 Stem Cell Transplantation 27 Granulocyte Colony-Stimulating Factor 21 Injections 20 asciminib 19 decitabine and cedazuridine drug combination 18 Sirolimus 18 Peripheral Blood Stem Cell Transplantation 18 Thiotepa 17 Filgrastim 17 nilotinib 16 X-Rays 14 Methotrexate 14 Imatinib Mesylate 14 Cyclosporine 14 Magnetic Resonance Spectroscopy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pharmaceutical Preparations × Myeloid × 1 year × Clear all

NCT04994158 2025-07-30

MASCOT-R

Royal Free Hospital NHS Foundation Trust

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡